Lindenwold Advisors Repligen Corp Transaction History
Lindenwold Advisors
- $187 Million
- Q2 2024
Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.08 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$726 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$660 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$249 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$204 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.95B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....